Literature DB >> 22533728

Tanshinones increase fibrinolysis through inhibition of plasminogen activator inhibitor-1.

Ying-Hong Xiao, Long-Fei Yang, Xue-Chao Feng, Hong Yang, Tong-Hui Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22533728      PMCID： PMC6493624          DOI： 10.1111/j.1755-5949.2012.00307.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  3 in total

1.  Effects of tanshinone combined with valsartan on hypertensive nephropathy and its influence on renal function and vascular endothelial function.

Authors:  Lizhu Chen; Jing Wu; Haishan Xu; Jie Chen; Xiaoqin Xie
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor.

Authors:  Yu Jiang; Guangping Zhang; Dong Yan; Hong Yang; Zuguang Ye; Tonghui Ma
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-18       Impact factor: 2.629

3.  Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum.

Authors:  Bo Yu; Guangping Zhang; Lingling Jin; Bo Zhang; Dong Yan; Hong Yang; Zuguang Ye; Tonghui Ma
Journal:  Front Pharmacol       Date:  2017-07-21       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.